Virological and immunological responses of efavirenz-based HAART regimen initiated in HIV-infected patients at CD4 < 100 versus CD4 > or = 100 cells/mm3.

Source:http://linkedlifedata.com/resource/pubmed/id/17100373

Download in:

View as

General Info

PMID
17100373